BUZZ-Progenics Pharmaceuticals Inc: FDA defers decision on drug

Mon Apr 4, 2016 8:53am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Drug developer's shares down 11.6 pct at $3.90 premarket

** FDA extends decision date for Progenics' drug oral Relistor, a treatment for opioid-induced constipation, to July 19 from April 16

** Progenics co-developing drug with Valeant Pharmaceuticals International Inc

** FDA says three-month extension needed to review additional data

** Up to Friday's close, stock had fallen 28 pct this year